Prevalence of pre-existing risk factors for adverse events associated with atypical antipsychotics among commercially insured and medicaid insured patients newly initiating atypical antipsychotics.
about
Pharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published Literature.Lack of tolerable treatment options for patients with schizophrenia.Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to bCariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
P2860
Prevalence of pre-existing risk factors for adverse events associated with atypical antipsychotics among commercially insured and medicaid insured patients newly initiating atypical antipsychotics.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prevalence of pre-existing ris ...... ating atypical antipsychotics.
@ast
Prevalence of pre-existing ris ...... ating atypical antipsychotics.
@en
type
label
Prevalence of pre-existing ris ...... ating atypical antipsychotics.
@ast
Prevalence of pre-existing ris ...... ating atypical antipsychotics.
@en
prefLabel
Prevalence of pre-existing ris ...... ating atypical antipsychotics.
@ast
Prevalence of pre-existing ris ...... ating atypical antipsychotics.
@en
P2093
P1433
P1476
Prevalence of pre-existing ris ...... ating atypical antipsychotics.
@en
P2093
Anagha Nadkarni
Iftekhar Kalsekar
John J Sheehan
Siddhesh A Kamat
Stephen Johnston
P304
P356
10.2174/1574886309666140601211551
P577
2014-01-01T00:00:00Z